Regulatory/Legislative News

The FDA has approved a clinical study of the Implantable Miniature Telescope in patients with age-related macular degeneration who were previously implanted with an IOL, according to a VisionCare press release.

Calling it a “complete and total disaster,” President-elect Donald J. Trump today reaffirmed he will repeal and replace the Affordable Care Act.

This month will mark the beginning of a new era in American health care. The new Republican president has pledged to repeal and replace the Affordable Care Act as soon as he takes office.

The FDA has approved Abbott’s Star S4 IR excimer laser system and iDesign Advanced WaveScan Studio System for use in LASIK patients with mixed astigmatism, according to Abbott correspondence.

The FDA has granted orphan drug designation to a drug candidate for the treatment of Stargardt disease, Acucela announced in a press release.

President Barack Obama, JD, said it would be “reckless” for Republicans to repeal the Affordable Care Act without having a suitable replacement ready to go.

Genentech announced the FDA approved Lucentis for the treatment of myopic choroidal neovascularization, the fifth FDA-approved indication for the drug.

From international law firm Arnold & Porter Kaye Scholer LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

Alcon, a division of Novartis, announced that it is discontinuing the unilateral pricing policy for its contact lenses in light of a Utah district court’s decision to uphold the Contact Lens Consumer Protection Act.

The FDA has approved Alcon’s AcrySof IQ ReSTOR +3.0 D multifocal toric IOL, according to a company press release.